Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

Massimo Filippi; Maria A. Rocca; Elisabetta Pagani; Nicola De Stefano; Douglas Jeffery; Xavier Montalbán; Gıancarlo Comı; Massimo Filippi; Maria A. Rocca; Martina Absinta; Giulia Longoni; Sebastiano Galantucci; Elisabetta Pagani; Luca Dall’Occhio; Paolo Misci; Melissa Petrolini; Stefania Sala; Roberto Vuotto; Massimo Filippi; Xavier Montalbán; H. McFarland; Kenneth A. Bauer; N. Galay; Johannes Weber; Claudia Franta; C. Lampi; Penko Shotekov; S Bozhinov; Надежда Делева; L. Haralanov; Svetlana Hristova; Igor Petrov; Ivan Milanov; M. Kremenchutzky; Hyman H. Rabinovitch; Christiane Ayotte; François Grand’Maison; Albert Lamontagne; Richard Leckey; L. H. N. Lee; Pavel Hradílek; Petr Kaňovský; Katrin Gross‐Paju; Pille Taba; P. Vermersch; L. Rumbach; Pierre Clavelou; Cyrille B. Confavreux; Jean Pelletier; Gilles Edan; R Shakarishvili; Alexander Tsiskaridze; E. Becker; Andrew Chan; Jeffrey S. Eggers; Jürgen Haas; C. Heesen; Fedor Heidenreich; J. Koehler; H. W. Koelmel; Ralf A. Linker; Patrick Oschmann; Sebastian Rauer; M. Maschke; Meike Mueller; Gerd Reifschneider; Britt Wildemann; Alice Steinbrecher; Hayrettin Tumani; Uwe Ziebold; Tjalf Ziemssen; J. Kanya; Gábor Jakab; A. Valikovics; Laura M. Bartos; D. Karussis; Hanna Rawashdeh; Arnon Karni; Jeremy R. Chapman; D. Caputo; Diego Centonze; Salvatore Cottone; Angelo Ghezzi; Davide Maimone; E. Montanari; Katrin Plewnia; Elio Scarpini; Marco Metra; Daiva Rastenytė; S. Sceponaviciute; Bas de Jong; S. T. F. M. Frequin

doi:10.1136/jnnp-2013-306132

Related publications

Article2012

Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis

Gıancarlo Comı, Douglas Jeffery, Ludwig Kappos, Xavier Montalbán, Alexey Boyко, Maria A. Rocca, Massimo Filippi

Article2021

CONCERTO: A randomized, placebo-controlled trial of oral laquinimod in relapsing-remitting multiple sclerosis

Gıancarlo Comı, Yuval Dadon, Noah J. Sasson, Joshua R. Steinerman, Volker Knappertz, Timothy Vollmer, Alexey Boyко, Patrick Vermersch, Tjalf Ziemssen, Xavier Montalbán, Fred Lublin, Maria A. Rocca, Rita Volkinshtein, Svetlana Rubinchick, Nitsan Halevy, Massimo Filippi

Article2013

Comparison of Early and Delayed Oral Laquinimod in Patients with Relapsing-Remitting Multiple Sclerosis: Effects on Disability Progression at 36 Months in the ALLEGRO Trial (S41.004)

Gıancarlo Comı, Ludwig Kappos, Xavier Montalbán, Alexey Boyко, Maria A. Rocca, Massimo Filippi

Article2025

Effects of cognitive rehabilitation and exercise on brain structure in progressive multiple sclerosis: results from the CogEx trial

Francesco Romanò, Maria A. Rocca, Elisabetta Pagani, Maria Pia Amato, Giampaolo Brichetto, Jeremy Chataway, Nancy D. Chiaravalloti, Gary Cutter, Ulrik Dalgas, Rachel Farrell, Peter Feys, Jennifer Freeman, Matilde Inglese, Emilio Cipriano, Cecilia Meza, Robert W. Motl, Amber Salter, Brian M. Sandroff, Anthony Feinstein, Massimo Filippi

Article2015

Baseline characteristics of patients enrolled in CONCERTO - a study of 0.6 and 1.2 mg/day oral laquinimod for relapsing-remitting multiple sclerosis (P7.216)

Gıancarlo Comı, Timothy R. Vollmer, Xavier Montalbán, Tjalf Ziemssen, Alexey Boyко, Patrick Vermersch, Tamar Rachmilewitz, Noah J. Sasson, Tali Gorfine, Volker Knappertz, Maria A. Rocca, Massimo Filippi